Skip to content

Type 2 Inflammation Skin Diseases Cohort Study

Type 2 inflammation skin diseases cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089117
Enrollment
Unknown
Registered
2024-09-02
Start date
2024-09-10
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 inflammation skin disease

Interventions

adult group (above 18 years old), youth group (8-18 years old), and child group (below 8 years old):None

Sponsors

Shenzhen Center for Chronic Disease Control
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with type 2 inflammatory skin diseases (atopic dermatitis, dermatitis/eczema, urticaria, pemphigoid, nodular prurigo). (2) There is no age range. (3) The patient and/or his/her guardian and/legal representative fully understand the content of the program and agree to participate.

Exclusion criteria

Exclusion criteria: (1) Patients who cannot be clearly diagnosed as type 2 inflammatory skin diseases. (2) The patient cannot understand or does not agree to participate in this project. (3) Patients with other critical conditions, such as acute infection, acute myocardial infarction, etc. (4) Patients with mental or psychological diseases who are unable to understand or cooperate with the completion of the program (such as schizophrenia, autism, etc.).

Design outcomes

Primary

MeasureTime frame
Serum total IgE;

Secondary

MeasureTime frame
Number of eosinophils in peripheral blood;

Countries

CHINA

Contacts

Public ContactHui Liu

Shenzhen Center for Chronic Disease Control

NHDX2016LIUHUI@163.com+86 156 0239 5880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026